Drug intelligence / Profile preview

talampicillin

Development stage
Discontinued
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

Talampicillin is an orally administered beta-lactam antibiotic from the penicillin family. It is a prodrug of ampicillin, designed to improve oral absorption and bioavailability compared to ampicillin itself. After oral administration, it is rapidly absorbed and hydrolyzed by tissue esterases in the intestinal wall to release active ampicillin and 2-hydroxymethyl-benzoic acid; no unchanged talampicillin appears in peripheral blood. Its mechanism of action involves inhibition of bacterial cell wall synthesis by targeting penicillin-binding proteins (PBPs), leading to bacterial cell lysis and death. Talampicillin was developed as an acid-stable alternative for oral use but has not been approved by the FDA for use in the United States[1][4][5][6][7].

Brand names
Talpen
Other names
talampicilinatalampicillinetalampicillinumampicillin, phthalidylphthalidyl ampicillinhydrochloride, talampicillintalampicillin hydrochloride
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on talampicillin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on talampicillin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call